FIGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FIGS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The business is improving fundamentally, but the pre-market drop of 13.47% creates uncertainty, and the stock is still not showing a clean technical buy signal. I would not buy it at this moment; I would wait for price stability above support or a clearer rebound.
FIGS is in pre-market at 13.3, down 13.47%, which is a sharp negative reaction. Technically, MACD histogram is -0.125 and still below zero, though contracting, so downside momentum is easing but not fully reversed. RSI_6 at 56.52 is neutral, and moving averages are converging, which suggests consolidation rather than a strong trend. Key levels are Pivot 15.474, R1 16.83, S1 14.118, and S2 13.28. The stock is currently below S1 and very near S2, which makes the current setup weak for immediate buying. The short-term pattern data also points to mild downside pressure over the next day, week, and month.
["Q1 revenue grew 28.02% YoY to 159.9M, showing strong top-line momentum.", "Gross margin improved to 67.73%, indicating solid operational efficiency.", "Analysts have been broadly raising targets and improving ratings after earnings, reflecting stronger fundamentals.", "KeyBanc, Roth Capital, BTIG, and Oppenheimer all turned more constructive, citing durable growth and better execution.", "Options positioning is heavily call-skewed, suggesting bullish sentiment among traders."]
["Pre-market price is down 13.47%, showing a strong negative reaction right now.", "Net income fell sharply year over year despite revenue growth, so profitability remains uneven.", "MACD remains negative and the stock is below near-term support levels.", "No AI Stock Picker signal and no recent SwingMax signal today.", "The stock trend model suggests downside bias over the next day, week, and month.", "No meaningful hedge fund, insider, congress, or influential political buying support is shown."]
In Q1 2026, FIGS delivered 28.02% YoY revenue growth to 159.9M, which is a strong growth rate for the latest quarter. Gross margin improved slightly to 67.73%, supporting the idea of better operating quality. EPS was flat at 0.03, while net income was only 6.3M and down sharply year over year, so profitability is still not consistently strong. Overall, the latest quarter was a solid revenue-growth quarter, but earnings quality remains mixed.
Analyst sentiment has clearly improved over the last few months. KeyBanc raised its target to 19 and kept Overweight, Roth Capital raised to 18 and kept Buy, Morgan Stanley lifted its target to 15 but stayed Equal Weight, Oppenheimer upgraded to Outperform with a 22 target, Telsey raised to 17 with Market Perform, BTIG raised to 20 with Buy, Goldman upgraded to Neutral with a 14 target, and KeyBanc again reiterated confidence. Wall Street’s pro view is that FIGS has structurally improving fundamentals, stronger execution, and room for sustained growth and margin expansion. The con view is that after a large run-up, valuation may already reflect much of the recovery and further upside needs continued high growth.
